Terumo Corporation (TYO:4543)

Market Cap	3.68T
Revenue (ttm)	1.04T
Net Income (ttm)	124.93B
Shares Out	1.48B
EPS (ttm)	84.50
PE Ratio	29.49
Forward PE	23.92
Dividend	30.00 (1.20%)
Ex-Dividend Date	Sep 29, 2025

Volume	1,162,800
Average Volume	4,068,635
Open	2,457.50
Previous Close	2,491.50
Day's Range	2,455.00 - 2,540.00
52-Week Range	2,352.00 - 3,182.00
Beta	0.33
RSI	46.35
Earnings Date	Nov 12, 2025

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4543

Financial Performance

In 2024, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.